SMS Pharma surges on receiving USFDA’s nod for manufacturing facility in AP

28 Dec 2015 Evaluate

SMS Pharmaceuticals is currently trading at Rs. 133.75, up by 10.75 points or 8.74% from its previous closing of Rs. 123.00 on the BSE.

The scrip opened at Rs. 133.00 and has touched a high and low of Rs. 137.50 and Rs. 130.25 respectively. So far 230798 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 137.50 on 21-Dec-2015 and a 52 week low of Rs. 38.60 on 07-Jan-2015.

Last one week high and low of the scrip stood at Rs. 137.50 and Rs. 116.50 respectively. The current market cap of the company is Rs. 1123.76 crore.

The promoters holding in the company stood at 64.97% while Institutions and Non-Institutions held 0.41% and 34.61% respectively.

SMS Pharmaceuticals has received approval from the US Food and Drug Administration (USFDA) for its manufacturing facility located at Kandivalasa village in Vizianagaram district of Andhra Pradesh. The USFDA had conducted inspection of the plant in the third week of April this year.

SMS Pharmaceuticals is engaged in manufacturing of active pharmaceutical ingredients (API) and currently has four production facilities and two research centers in operation.



SMS Pharmaceuticals Share Price

316.70 -7.20 (-2.22%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×